9 articles
Anthropic established a physical biology lab to advance AI-driven drug discovery, partnering with major pharma firms like Novartis and Roche. The company acquired Coefficient Bio to accelerate develop
Novo Nordisk has partnered with Anthropic to integrate Claude AI models into its R&D workflows for accelerated drug discovery. The collaboration aims to shorten research timelines and improve scientif
Anthropic reported blocking attempts to use its AI models for biological weapons research, citing gain-of-function studies on the chikungunya virus and implementing stricter safeguards on newer models
TAR secured $120 million in Series A funding led by Spark Capital to deploy modular off-grid power systems combining solar, batteries, and natural gas for data centers.
Anthropic launched the Model Hardware Standard, enabling AI agents to control lab and manufacturing instruments like robotic arms. This aims to accelerate autonomous workflows in drug discovery and sc
C&EN releases its annual Global Top 50 chemical firms ranking ahead of schedule, alongside coverage of Anthropic's new science tool and AstraZeneca's renewed collaboration with CSPC.
Backed by Big Tech, the Frontier coalition increased its carbon removal funding pledge by $915 million to $1.8 billion, adding Anthropic as a participant. Funds will target technologies like direct ai
Bristol Myers Squibb partners with Anthropic to deploy Claude AI across 30,000 employees to accelerate drug discovery and manufacturing. The initiative aims to leverage agentic AI to potentially boost
Anthropic and the Gates Foundation announced a $200 million partnership to support AI public goods in health and education. One initiative aims to use AI to predict drug candidates for diseases like H
ChemBrief